Journal Flyer

Online Journal of Cardiology Research & Reports - OJCRR

ISSN: 2693-4965

Managing Editor: Catherine Ali

Contact us at:

Open Access Opinion

Risks and Benefits of Febuxostat in the Cardiovascular Field, from Trials to the Real World, and State of the Art in Italy

Valerio Massimo Magro1*, Eugenio Boccalone1, Michele Caturano2, Giovanni Scala3 and Walter Verrusio4

1Department of Internal Medicine and Geriatrics, University of Campania “Luigi Vanvitelli”, Italy

2Department of Internal Medicine, AORN San Giovanni di Dio e Ruggi d’Aragona, Salerno, Italy

3ASL RM2 Home Care Center, Rome, Italy

4Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, Sapienza University of Rome, Rome, Italy

Corresponding Author

Received Date: August 12, 2019;  Published Date: August 27, 2019

Abstract

Pharmacovigilance is the set of activities whose objective is to provide, on an ongoing basis, the best possible information on the safety of drugs, using the appropriate measures and thus ensuring that the drugs available on the market present, in the authorized use conditions, a favorable risk-benefit ratio for the population. There is a “Pharmacovigilance” section of the body responsible for it (Italian Drug Agency, Agenzia Italiana del Farmaco – AIFA).

Article Details
Citation

  • Valerio Massimo Magro, Eugenio Boccalone, Michele Caturano, Giovanni Scala, Walter Verrusio. Risks and Benefits of Febuxostat in the Cardiovascular Field, from Trials to the Real World, and State of the Art in Italy. On J Cardio Res & Rep. 2(4): 2019. OJCRR.MS.ID.000541.

Signup for Newsletter
  • newsletter-subscription
© 2018 Iris Publishers LLC, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use. Creative Commons License Open Access by
Iris Publishers LLC is licensed under Creative Commons License a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com. Best viewed in browser_icons browser_icons | Above IE 9.0 version | Privacy Policy
Scroll to Top